PRESERVE-004/GOG Phase 2 Randomized dose optimization trial ot gotistobart
Back to course
Video Transcription
Video Summary
Asset Subtitle
Joyce Barlin
March 2025
Keywords
Gotistibart
Pembrolizumab
ovarian cancer
clinical trial
anti-CTLA4 antibody
Contact education@igcs.org for assistance.
Powered By